Drug shortages continue to create significant financial and operational strain on hospitals, impacting both patient care and workforce efficiency. In a video interview with Pharma Commerce, Boyede Sobitan, global healthcare…
Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics, data & tech, and healthcare innovation. I’m your host, and…
Drug shortages continue to create significant financial and operational strain on hospitals, impacting both patient care and workforce efficiency. In a video interview with Pharma Commerce, Boyede Sobitan, global healthcare…
Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics, data & tech, and healthcare innovation. I’m your host, and…
Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics, data & tech, and healthcare innovation. I’m your host, and…
Avinob Roy, Vice President & General Manager of Global Commercial Product Offerings at IQVIA, spoke with Pharmaceutical Commerce about how advancements in AI, particularly agentic AI, are reshaping the future…
Image Credit: Adobe Stock Images/Philip.com Last night, the Trump administration requested that the US Supreme Court hear out an appeal to overturn a previous ruling by a lower court declaring…
Image Credit: Adobe Stock Images/SundryPhotography.com Gilead Sciences has unveiled its new Pharmaceutical Development and Manufacturing (PDM) Technical Development Center (NTDC), nestled in the company’s Foster City, CA headquarters.1 The new…
Drug shortages continue to create significant financial and operational strain on hospitals, impacting both patient care and workforce efficiency. In a video interview with Pharma Commerce, Boyede Sobitan, global healthcare…
Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics, data & tech, and healthcare innovation. I’m your host, and…
The Prescription Information Modernization Act of 2025 (PIMA) is being hailed as a significant development for the pharmaceutical industry because it represents rare bipartisan agreement on an issue that directly…
Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics, data & tech, and healthcare innovation. I’m your host, and…
The Prescription Information Modernization Act of 2025 (PIMA) is being hailed as a significant development for the pharmaceutical industry because it represents rare bipartisan agreement on an issue that directly…
The Prescription Information Modernization Act of 2025 (PIMA) is being hailed as a significant development for the pharmaceutical industry because it represents rare bipartisan agreement on an issue that directly…
Life science marketing is changing. Practices which worked for the blockbuster drug era are no longer appropriate for today’s environment of specialist medicines, flattened budgets, and rising customer expectations. Today’s…
In a video interview with Pharma Commerce, Dave Malenfant, a healthcare supply chain expert, discusses the potential impact of a proposed 250% tariff on pharmaceutical imports, emphasizing that the effect…
Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics, data & tech, and healthcare innovation. I’m your host, and…
Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics, data & tech, and healthcare innovation. I’m your host, and…
This video was created based on various Pharma Commerce articles: AbbVie Invests $195 Million to Expand Stateside API Manufacturing AstraZeneca Commits $50 Billion to US Manufacturing and R&D Efforts by…
Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics, data & tech, and healthcare innovation. I’m your host, and…
Thani Jambulingam, PhD, professor of food, pharma, and healthcare business at Saint Joseph’s University’s Erivan K. Haub School of Business, outlines examples of obstacles faced by the pharma supply chain,…
Pharmaceutical Commerce presents The Most Favored Nation Mandate webinar! Earlier this year, Donald Trump issued an executive order stating that pharma companies must treat the United States as a most-favored-nation…
Image Credit: Adobe Stock Images/KKStock.com With an increase in price forthcoming, Eli Lilly has decided to temporarily pause UK shipments of Mounjaro1—the company’s branded form of tirzepatide that is approved…
Image Credit: Cold Chain Technologies Cold Chain Technologies (CCT), is solidifying its commitment to growing its Asia-Pacific (APAC) presence by continuing to seek out new investment and partnership opportunities across…
In a video interview with Pharma Commerce, Dave Malenfant, a healthcare supply chain expert, discusses the potential impact of a proposed 250% tariff on pharmaceutical imports, emphasizing that the effect…
Credit: Tada Images | stock.adobe.com The FDA has authorized the use of updated COVID-19 vaccines for the upcoming fall season, with eligibility limited to adults aged 65 years and older…
Image Credit: Adobe Stock Images/Ajay.com Today, Aug. 27, marks an important milestone for Drug Supply Chain Security Act (DSCSA) implementation: the close of the exemption period for pharmaceutical distributors. The…
Image Credit: Adobe Stock Images/MichaelVi.com Yesterday, Genentech, a biotech company that is a member of the Roche Group, officially broke ground on its most recent US manufacturing plant—a 700,000 square-foot…
In a video interview with Pharma Commerce, Mark Lee, MarqVision’s founder and CEO, highlights the rapid growth and increasing sophistication of the counterfeit pharmaceutical market, driven in large part by…
Image Credit: Adobe Stock Images/DreamerStudio.com DSCSA stands for the Drug Supply Chain Security Act, and is enforced by the FDA. It was originally signed into law aspart of the Drug…
Image Credit: Adobe Stock Images/TadaImages.com Novo Nordisk has some facility issues to address. As first reported by STAT News,1 the company’s Bloomington, IN plant that was acquired as part of…
In a recent interview with Pharmaceutical Commerce, Ron Lanton, partner at Lanton Law, discussed the high-stakes implications of a new lawsuit filed by leading medical organizations to restore access to…
Image Credit: Adobe Stock Images/MichaelVi.com Johnson & Johnson is all in on domestic manufacturing. The company announced plans to boost its North Carolina presence by constructing a 160,0000-plus-square-foot manufacturing facility…
Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics, data & tech, and healthcare innovation. I’m your host, and…
In a recent interview with Pharmaceutical Commerce, Ron Lanton, partner at Lanton Law, discussed the high-stakes implications of a new lawsuit filed by leading medical organizations to restore access to…
Image Credit: Adobe Stock Images/ImagingL.com Following an eight-day bench trial, a judge has issued a final judgement ruling that pharmacy benefits manager Caremark—a subsidiary of CVS Health—must pay $289.9 million…
In this Pharmaceutical Commerce roundtable discussion, Nicholas Saraceno, editor of Pharmaceutical Commerce and the peer exchange’s moderator, introduced a discussion on the pharmaceutical supply chain, highlighting its complexity and importance…
Image Credit: Adobe Stock Images/Aquir.com As noted by Pharm Exec,1 the White House and European Union today revealed a framework for a deal centered around “reciprocal, fair, and balanced trade”…
In a video interview with Pharma Commerce, Mark Lee, MarqVision’s founder and CEO, highlights the rapid growth and increasing sophistication of the counterfeit pharmaceutical market, driven in large part by…
Image Credit: Adobe Stock Images/PostmodernStudio.com Endpoints News coverage1 has reported that Catalent, a global contract development and manufacturing organization (CDMO), is downsizing. The CDMO cites an “unexpected shift in demand…
In a video interview with Pharma Commerce, Dave Malenfant, a healthcare supply chain expert, discusses the potential impact of a proposed 250% tariff on pharmaceutical imports, emphasizing that the effect…
In a video interview with Pharma Commerce, Mark Lee, MarqVision’s founder and CEO, highlights the rapid growth and increasing sophistication of the counterfeit pharmaceutical market, driven in large part by…
Image Credit: Adobe Stock Images/Parintron.com Via financial support from the US Department of Health and Human Services (HHS) Administration for Strategic Preparedness and Response (ASPR) Office of Industrial Base Management…
Payer-focused reporting should not just identify winners and losers, but rather, it should drive a benchmarking process that informs strategy and guides activity. Embracing this maxim means that executive-level reports…
In a video interview with Pharma Commerce, Mark Lee, MarqVision’s founder and CEO, highlights the rapid growth and increasing sophistication of the counterfeit pharmaceutical market, driven in large part by…
It’s been about six months since the trade wars pitting the US vs. various global nations and regions have commenced, and in my unbiased opinion, Pharmaceutical Commerce has done as…
Mike Hennessy Jr, chairman and CEO, MJH Life Sciences Every stakeholder’s role in the pharmaceutical supply chain is just as important as the next, and that certainly holds true for…
Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics, data & tech, and healthcare innovation. I’m your host, and…
This video was created based on Bill Roth’s “Popping the Gross-to-Net Bubble” article series. Welcome to the explainer. Today, we are talking about the wild and honestly, super complex world…
Image Credit: Adobe Stock Images/Thanayut.com Goodpath, a virtual clinic for chronic health conditions, has reached a pharmacy integration deal with GiftHealth, Eli Lilly and Company’s LillyDirect pharmacy provider.1 LillyDirect is…
In this Pharmaceutical Commerce roundtable discussion, Nicholas Saraceno, editor of Pharmaceutical Commerce and the peer exchange’s moderator, introduced a discussion on the pharmaceutical supply chain, highlighting its complexity and importance…
View the Pharmaceutical Commerce August 2025 issue in an interactive format.
DSCSA: Recent Timeline May 27, 2025: Final enforcement begins. After an 18-month “stabilization” grace period, the FDA officially started enforcing DSCSA’s full suite of final requirements—including mandatory electronic, serialized exchange…
In a video interview with Pharma Commerce, Mark Lee, MarqVision’s founder and CEO, highlights the rapid growth and increasing sophistication of the counterfeit pharmaceutical market, driven in large part by…
340B: Recent Timeline July 31, 2025: HRSA launches 340B Rebate Model Pilot. The US Health Resources & Services Administration (HRSA) formally opened a voluntary Rebate Model Pilot Program, inviting select…
In a video interview with Pharma Commerce, Dave Malenfant, a healthcare supply chain expert, discusses the potential impact of a proposed 250% tariff on pharmaceutical imports, emphasizing that the effect…
Key Takeaways Pharma brands should evaluate AI in patient services by asking outcome-focused questions—how it improves patient care and brand performance—not just how it reduces costs. Effective AI solutions should…
Key Takeaways Patient access to treatment remains poor. For the second year in a row, patients with chronic conditions rated health plan access a “D,” with nearly half facing insurance-related…
In a video interview with Pharma Commerce, Philip Sclafani, PwC’s pharmaceutical and life sciences lead, he describes how the One Big Beautiful Bill Act (OBBBA) is expected to significantly influence…
In a video interview with Pharma Commerce, Philip Sclafani, PwC’s pharmaceutical and life sciences lead, he describes how the One Big Beautiful Bill Act (OBBBA) is expected to significantly influence…
Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics, data & tech, and healthcare innovation. I’m your host, and…
Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics, data & tech, and healthcare innovation. I’m your host, and…
In the highly regulated world of life sciences, compliance isn’t just a box to check; it is the foundation of product quality, patient safety, and business viability. GxP guidelines, encompassing…
Image Credit: Adobe Stock Images/PostmodernStudio.com At a time when more than 50% of pharmaceuticals distributed in the United States are produced overseas, the FDA has introduced PreCheck, a new program…
In this Pharmaceutical Commerce roundtable discussion, Nicholas Saraceno, editor of Pharmaceutical Commerce and the peer exchange’s moderator, introduced a discussion on the pharmaceutical supply chain, highlighting its complexity and importance…
Image Credit: Adobe Stock Images/DavideBonaldo.com Last week, President Trump issued letters to 17 of the largest pharmaceutical companies, expressing dire urgency for making changes along the drug pricing front.1 These…
In a video interview with Pharma Commerce, Philip Sclafani, PwC’s pharmaceutical and life sciences lead, he describes how the One Big Beautiful Bill Act (OBBBA) is expected to significantly influence…
Image Credit: Adobe Stock Images/Ibnu.com Novo Nordisk recently filed 14 new lawsuits intended to protect patients from unapproved compounded drugs that falsely claim to contain semaglutide. The defendants that are…
In a video interview with Pharma Commerce, Heather Zenk, Cencora’s president of US supply chain, describes how today’s distribution networks must seamlessly connect manufacturers to care sites that range from…
Image Credit: Adobe Stock Images/Ishika.com Noom, an online weight loss company, is unveiling its Microdose GLP-1Rx Program, a service intended to limit side effects via personalized microdoses of GLP-1s, when…
In a video interview with Pharma Commerce, Heather Zenk, Cencora’s president of US supply chain, describes how today’s distribution networks must seamlessly connect manufacturers to care sites that range from…
Image Credit: Adobe Stock Images/JozefMicic.com Esteve has purchased Regis Technologies, a Chicago-based contract development and manufacturing organization (CDMO), for an undisclosed amount.1 The deal provides Esteve CDMO—a Spain-based, third-party CDMO…
In a video interview with Pharma Commerce, Heather Zenk, Cencora’s president of supply chain operations & distribution services, describes how today’s distribution networks must seamlessly connect manufacturers to care sites…
What Clinical Ops Teams Must Know About Biomarkers in Trials In an interview with Applied Clinical Trials, Michael Miller, COO of Quanterix, emphasized that clinical operations teams must carefully consider…
In a video interview with Pharma Commerce, Heather Zenk, Cencora’s president of supply chain operations & distribution services, describes how today’s distribution networks must seamlessly connect manufacturers to care sites…
Image Credit: Adobe Stock Images/AMuhSakaria.com As large pharmacy retailers scale back operations, community pharmacies—particularly those embedded within grocery stores—are stepping into expanded roles as accessible healthcare touchpoints. This shift reflects…
Credit: Ascannio | stock.adobe.com. The FDA has issued a second complete response letter (CRL) to Regeneron’s odronextamab based on issues with a third-party manufacturing site, Catalent Indiana LLC, the company…
In this Pharmaceutical Commerce roundtable discussion, Nicholas Saraceno, editor of Pharmaceutical Commerce and the peer exchange’s moderator, introduced a discussion on the pharmaceutical supply chain, highlighting its complexity and importance…
As reported by Pharma Commerce sister publication, Pharmaceutical Executive,1 President Trump recently issued letters to 17 of the largest pharmaceutical companies, expressing urgency for making changes along the drug pricing…
In a video interview with Pharma Commerce, Nate Chenenko, principal with Ducker Carlisle, sheds light on the critical issue of Scope 3 emissions and their growing relevance in the pharmaceutical…
Image Credit: Adobe Stock Images/PeopleGraphics.com As the month of July winds down, the trade wars featuring the United States versus all other nations have been in full swing for about…
In a video interview with Pharma Commerce, Nate Chenenko, principal with Ducker Carlisle, sheds light on the critical issue of Scope 3 emissions and their growing relevance in the pharmaceutical…
With there being challenges in analyzing OOPCs that were related to certain cancer diagnoses in patients that privately insured, a retrospective cohort study published in JAMA Network Open sought toinvestigate…
In a video interview with Pharma Commerce, Hyung Heon Kim, CEO of MetaVia, describes how the current US payer ecosystem, including commercial insurers and Medicaid, exhibits a divided approach when…
President Trump reached a formal trade agreement with the European Union in which a maximum 15% levy will be imposed on “most” EU exports, including autos and their parts; semiconductors;…
In a video interview with Pharma Commerce, Nate Chenenko, principal with Ducker Carlisle, sheds light on the critical issue of Scope 3 emissions and their growing relevance in the pharmaceutical…
PC: As CGTs expand to serve broader patient populations, what strategies can developers use to overcome market access barriers such as payer skepticism and limited reimbursement pathways? Kevin Chinn: Central…
Balancing DEI Reporting with Legal Risk In an interview with Applied Clinical Trials, Kate Gallin Heffernan, a life sciences attorney at Epstein Becker Green, discussed how clinical research teams can…
In a video interview with Pharma Commerce, Brad Stewart, BDO’s national life sciences co-leader, describes how a proposed 200% tariff on pharmaceutical imports could have significant short- and long-term impacts…
In a video interview with Pharma Commerce, Brad Stewart, BDO’s national life sciences co-leader, describes how a proposed 200% tariff on pharmaceutical imports could have significant short- and long-term impacts…
In this Pharmaceutical Commerce roundtable discussion, Nicholas Saraceno, editor of Pharmaceutical Commerce and the peer exchange’s moderator, introduced a discussion on the pharmaceutical supply chain, highlighting its complexity and importance…
Image Credit: Adobe Stock Images/Sardar Key Takeaways Expanded Educational Access: Cold Chain Technologies (CCT) partners with E&I Cooperative Services to provide over 6,000 educational institutions expedited access to advanced cold…
Sixty percent of life sciences and healthcare leaders are anticipating that the current or forthcoming tariffs and pricing policies will have “some impact” on their businesses. Image Credit: Adobe Stock…
Patient safety and medication adherence are some of the major concerns in the pharmaceutical industry. With an increase in medication errors, counterfeit medicines, and supply chain mismanagement, the industry has…
The controversy surrounding embattled gene therapy company Sarepta Therapeutics, including its drug, Elevidys, for Duchenne muscular dystrophy, continues to captivate industry observers—with the latest twist being Sarepta’s decision late Monday…
In a video interview with Pharma Commerce, Brad Stewart, BDO’s national life sciences co-leader, describes how a proposed 200% tariff on pharmaceutical imports could have significant short- and long-term impacts…
The European Union intends to impose a 30% tariff on US imports valued at $117 billion if a trade deal is not reached. Image Credit: Adobe Stock Images/Khwankhae.com The European…
In a video interview with Pharma Commerce, Brad Stewart, BDO’s national life sciences co-leader, describes how a proposed 200% tariff on pharmaceutical imports could have significant short- and long-term impacts…
In a video interview with Pharma Commerce, Sean O’Hearen, founder and principal consultant at 1st Line Partners, discusses the critical issue of substandard and falsified (SF) medicines and the lack…
The combination of both parties’ offerings is a platform for managing the entire journey, from order to therapy initiation. Image Credit: Adobe Stock Images/NicoElNino.com Knipper Health has purchased eBlu Solutions,…
Inside the GLP-1 Strategy Driving Competitive Edge in Obesity Clinical Research In an interview with Applied Clinical Trials, Shipra Patel, global therapeutic area section head for endocrinology and global head…
In a video interview with Pharma Commerce, Sean O’Hearen, founder and principal consultant at 1st Line Partners, discusses the critical issue of substandard and falsified (SF) medicines and the lack…
How Parexel Supports Cross Functional Trials for Emerging GLP-1 Therapies In an interview with Applied Clinical Trials, Shipra Patel, global therapeutic area section head for endocrinology and global head of…
In a video interview with Pharma Commerce, Sean O’Hearen, founder and principal consultant at 1st Line Partners, discusses the critical issue of substandard and falsified (SF) medicines and the lack…
In this Pharmaceutical Commerce roundtable discussion, Nicholas Saraceno, editor of Pharmaceutical Commerce and the peer exchange’s moderator, introduced a discussion on the pharmaceutical supply chain, highlighting its complexity and importance…
Resilience, which is the concept of defying adversity and recovering from hardship, is connected to one’s health and well-being. Image Credit: Adobe Stock Images/Jaman_Visual.com Resilience, which is the concept of…
In a video interview with Pharma Commerce, Murray Aitken, executive director of the IQVIA Institute for Human Data Science, explains the extensive process behind developing the “Global Use of Medicines…
President Trump noted that the pharma sector should prepare for levies by the beginning of next month, which could coincide with the planned reciprocal tariffs rates that were previously set.…
Image Credit: Adobe Stock Images/ASDF Key Takeaways Strategic site acquisition: Thermo Fisher will acquire Sanofi’s sterile drug product manufacturing facility in Ridgefield, NJ, expanding its US-based fill-finish capabilities. Workforce integration:…
In a video interview with Pharma Commerce, Sean O’Hearen, founder and principal consultant at 1st Line Partners, discusses the critical issue of substandard and falsified (SF) medicines and the lack…
The consortium will be focused on deploying novel technologies to launch a fully automated, scalable, and hyper-efficient cell therapy manufacturing platform on a global scale. Image Credit: Cellular Origins Cellular…
In a video interview with Pharma Commerce, Sean O’Hearen, founder and principal consultant at 1st Line Partners, discusses the critical issue of substandard and falsified (SF) medicines and the lack…
Chandler’s pharmaceutical experience spans years in the pharma services space, powered by strategic leadership roles. Image Credit: Knipper Health Following Frazier Healthcare Partners’ investment in Knipper Health, Willis Chandler has…
LEO Pharma will pay Boehringer Ingelheim $105.2 million (€90 million) upfront, with the opportunity for additional payment, if specific milestones are met. Image Credit: Adobe Stock Images/JHVEPhoto.com Boehringer Ingelheim and…
Gilead plans to supply enough doses to assist up to two million individuals over three years in nations supported by the Global Fund. Image Credit: Adobe Stock Images/TobiasArhelger.com Gilead Sciences…
Few times in the evolution of a pharmaceutical company are as exciting as during the flurry of launch readiness activities focused on bringing a new drug to market. From the…
Removing Financial Barriers to Boost Trial Diversity In an interview with Applied Clinical Trials, Heather Horville, solutions consultant, Greenphire, emphasized the importance of removing financial and logistical barriers—such as through…
In this Pharmaceutical Commerce roundtable discussion, Nicholas Saraceno, editor of Pharmaceutical Commerce and the peer exchange’s moderator, introduced a discussion on the pharmaceutical supply chain, highlighting its complexity and importance…
Despite these medications being both available and affordable, racial, ethnic, and socioeconomic disparities came to light when it came to accessing COVID-19 treatment. Image Credit: Adobe Stock Images/Steheap.com As history…
In a video interview with Pharma Commerce, Marschall Runge, MD, PhD, dean of the University of Michigan Medical School and author of The Great Healthcare Disruption, addresses the potential impacts…
PC: In the absence of public participation at the federal level, how can industry leaders collaborate with advocacy groups to sustain meaningful engagement with regulators? Leuchter: Experienced regulators are very…
In a video interview with Pharma Commerce, Marschall Runge, MD, PhD, dean of the University of Michigan Medical School and author of The Great Healthcare Disruption, addresses the potential impacts…
July 9, 2025 Edward Ahn, CEO of MEDIPOST, Inc., reacts to the challenge of launching orphan drugs without complete evidence, particularly given their high cost and limited patient populations, and…
President Trump noted that import taxes on pharmaceuticals of up to 200% could come forthcoming. Image Credit: Adobe Stock Images/MohammadXte.com The pharmaceutical industry has been anxiously standing by, waiting on…
All of the levies come with a stipulation—if these nations increase their tariffs, the United States will raise them on its end as well. Image Credit: Adobe Stock Images/Zenday.com Yesterday,…
PC: How might this change affect payer negotiations and reimbursement decisions, particularly for innovative or high-cost therapies? Leuchter: When it comes to rare diseases, patients often suffer from a wide…
A qualitative study explored how representatives from MA plans, kidney care management companies, and dialysis organizations view the expansion and marketing of MA products for individuals with ESKD. Image Credit:…
The trust gap between real-world evidence (RWE)/data and randomized controlled trials is growing. This episode examines when each evidence type is appropriate, how to reduce perceived bias in RWE, and…
2025 DIA Annual Meeting: Building Patient Centricity into Clinical Trial Software from Day One In an interview with Applied Clinical Trials, Brian Ongioni, chief product officer, uMotif, discussed how the…
PC: What risks do you foresee for companies developing first-in-class therapies if patient perspectives are no longer formally incorporated into regulatory discussions? Leuchter: Eliminating patient perspectives from regulatory discussions would…
In a video interview with Pharma Commerce, Mark Sawicki, PhD, Cryoport Systems’ president and CEO, discusses the evolving state of global cell and gene therapy commercialization. Sawicki highlighted significant progress…
Preparing for Federal Regulations: Q&A with John Stanford In an interview with Pharmaceutical Executive, John Stanford, executive director at Incubate, emphasized the importance of sustained investment in early-stage biotech to…
In the fourth part of his Pharma Commerce video interview, Mark Sawicki, PhD, Cryoport Systems’ president and CEO, explains the lessons pharma leaders in traditional therapeutic areas can learn from…
Oncology Care Index Spurs J&J to Address Fragmentation in Cancer Treatment In an interview with Pharmaceutical Executive, Biljana Naumovic, US President, oncology, solid tumor, Johnson & Johnson Innovative Medicine, shared…
The Impact of FDA’s Ban on Compounded GLP-1s A Pharmaceutical Executive article explores how the FDA’s ban on compounded semaglutides—following stabilized supply from Novo Nordisk and Eli Lilly—has significantly disrupted…
This investment exemplifies Hikma’s interest in raising the volume of meds it creates and produces across its various R&D and manufacturing sites in Columbus and Cleveland, OH and in Cherry…
In a video interview with Pharma Commerce, Mark Sawicki, PhD, Cryoport Systems’ president and CEO, discusses the evolving state of global cell and gene therapy commercialization. Sawicki highlighted significant progress…
Historically, new drugs were approved for a single therapeutic use. However, industry trends have shifted, with pharmaceutical companies increasingly identifying and developing additional indications for existing medicines. This approach is…
PC: What role has public participation historically played in shaping healthcare policy, and why is it important for pharma and biotech companies? Leuchter: Public participation has played a critical role,…
Medicaid is especially critical for children with rare diseases, due to their need for intensive specialty care and higher risk for financial distress. Image Credit: Adobe Stock Images/Ivlianna.com In the…
Novo Nordisk is growing coverage of its Wegovy injection 2.4 mg in the form of a new deal with WeightWatchers that takes effect July 1. Image Credit: Adobe Stock Images/Syahrir.com…
Real-world evidence (RWE) is no longer optional—it’s expected. This episode dives into how payers assess RWE alongside clinical trial data, especially in competitive therapeutic areas. The panel stresses the importance…
2025 DIA Annual Meeting: The Importance of Early Patient Feedback in Digital Endpoint Development In an interview with Applied Clinical Trials at the 2025 DIA Annual Meeting, Brian Ongioni, chief…
In a video interview with Pharma Commerce, Mark Sawicki, PhD, Cryoport Systems’ president and CEO, discusses the evolving state of global cell and gene therapy commercialization. Sawicki highlighted significant progress…
How CRO Partnerships Are Evolving to Meet Changing Industry Demands In an interview with Applied Clinical Trials, Judith Ng-Cashin, MD, chief medical officer, Novotech, emphasized the need for CRO partnerships…
2025 DIA Annual Meeting: How AI and Machine Learning Can Improve Patient Reported Outcomes in Clinical Trials In an interview with Applied Clinical Trials, Brian Ongioni, chief product officer at…
In this Pharmaceutical Commerce roundtable discussion, Nicholas Saraceno, editor of Pharmaceutical Commerce and the peer exchange’s moderator, introduced a discussion on the pharmaceutical supply chain, highlighting its complexity and importance…
Pharmaceutical Commerce: FDA staff cuts have created a critical gap in adverse drug event (ADE) monitoring. With ADEs being the third leading cause of death in the United States,1 what…
Investigators aimed to examine the quality and efficiency under the FFS MA and at-risk MA models as a way to measure both the quality and resources that are being utilized.…
In a video interview with Pharma Commerce, Mark Sawicki, PhD, Cryoport Systems’ president and CEO, discusses the evolving state of global cell and gene therapy commercialization. Sawicki highlighted significant progress…
The purpose of the partnership is to help further develop the Treg and TIL cell therapies that are intended to fight autoimmune and solid tumor diseases. Image Credit: Adobe Stock…
As international price referencing tightens and payer expectations rise, companies face a shrinking margin for error. The panel explores how clinical trial design and early payer engagement are key to…
Stop Losing Patients at the Gate: The 24-Hour Window That Makes or Breaks Your Entire Hub Program
Image Credit: Adobe Stock Images/TadaImages.com As a result of the Patient Protection and Affordable Care Act (ACA), 24.2 million people enrolled in the health insurance marketplaces this year, a record…
Image Credit: Adobe Stock Images/StockMediaLabs.com Evaluate, who provides market insights for the pharma industry, has unveiled its “2025 World Preview Report,” which offers insights for the global pharmaceutical market through…
This Peer Exchange® starts off with an introduction of the panel: Edward Ahn, CEO of MEDIPOST, Inc.; Rob Philo, Founder and CEO of Core Market Access Advisors; and Shana Gunderson…
Pharmaceutical Commerce: June 2025 Interactive Digital Edition DSCSA Compliance: The Time is Now Conference Connect: Determining the Future of Specialty Pharmacy Bolstering Health Technology Assessment With the Help of AI…
TekniPlex Healthcare, a supplier of barrier films, unit-dose containers, and more, has opened its new 200,000-square-foot facility in Madison, WI, which was made official with a ribbon-cutting ceremony last week.…
Strategic Planning in the Rebate Economy: What Pharma Must Do Now A recent Pharmaceutical Executive article outlines how, despite decades of evolving policy from OBRA ’90 to the Inflation Reduction…
Building Strong CRO-Sponsor Partnerships to Improve Clinical Trial Success In an interview with Applied Clinical Trials, Judith Ng-Cashin, MD, chief medical officer at Novotech, emphasized the value of trust-based CRO-sponsor…
AI-GO blister inspection. Image Credit: Antares Vision Group Antares Vision Group, a provider of track-and-trace systems for several fields including the life sciences, and Oròbix, an artificial intelligence (AI) service…
In this Pharmaceutical Commerce roundtable discussion, Nicholas Saraceno, editor of Pharmaceutical Commerce and the peer exchange’s moderator, introduced a discussion on the pharmaceutical supply chain, highlighting its complexity and importance…
Image Credit: Adobe Stock Images/DigitalMagicVisions.com One of several public health issues of utmost importance are mental health disorders, which are quite commonplace. In the United States, millions of adults suffer…
In a video interview with Pharma Commerce, LeAnn Boyd, PharmD, Liviniti’s founder and CEO, discusses the deeper, systemic issues behind rising healthcare and drug costs that are not fully addressed…
Image Credit: Adobe Stock Images/Rawpixel.com Data show that nearly two-thirds of Medicare beneficiaries feel that their coverage completely meets their expectations. Despite this, a recent survey also showed that 15%…
Key Takeaways DSCSA enforcement deadlines are phasing in through 2025, with wholesalers and repackagers already required to comply as of May 27, and wholesale distributors facing an August 27 deadline—provided…
Key Takeaways AI enhances traditional HTA by improving accuracy and efficiency. Artificial intelligence addresses key limitations of traditional health technology assessments—such as data gaps and time-intensive processes—through automation, real-time data…
Key Takeaways Real-world data enhances medication safety and supply chain efficiency. By collecting and applying data from manufacturing through administration, stakeholders can optimize inventory, track usage trends, and improve predictive…
Key Takeaways Speed is Critical. The first 24 hours after a prescription are crucial—nearly half of patients are lost immediately without efficient onboarding. Rapid, streamlined hub services are essential to…
Image Credit: Adobe Stock Images/JHVEPhoto.com Key Takeaways UCB is investing $5 billion in a new US biologics manufacturing facility, aiming to boost its production capabilities, create 800 jobs, and strengthen…
In a video interview with Pharma Commerce, Kirsten Newquist, Identiv’s CEO, defines “smart pharma packaging” as the integration of technology into pharmaceutical packaging to enhance product identification, tracking, and patient…
Navigating the Intersection of Accessibility and Measurement Integrity in eCOA An article in Applied Clinical Trials explores how clinical research’s shift toward patient-centered outcomes is prompting the eCOA field to…
In a video interview with Pharma Commerce, Kirsten Newquist, Identiv’s CEO, defines “smart pharma packaging” as the integration of technology into pharmaceutical packaging to enhance product identification, tracking, and patient…
Key Takeaways Price hikes, not launch prices, drove the GTN bubble. The real driver of the gross-to-net (GTN) bubble was the pharmaceutical industry’s ability to raise drug prices year after…
Sticker shock at the pharmacy counter has become an all-too-familiar experience for both patients and providers. The rising cost of prescription medications in the United States creates a growing obstacle…
Key Takeaways Reintroduction of the MFN model. The Trump Administration has revived the most-favored nation (MFN) drug pricing model as a seven-year test, which would tie US drug prices to…
Image Credit: Adobe Stock Images/Tippapatt.com Key Takeaways DHL has acquired Cryoport’s specialty courier business, CRYOPDP, for approximately $200 million, strengthening its position in temperature-controlled logistics for the life sciences sector.…
June 12, 2025 Amy Niles, chief mission officer, PAN Foundation, provides a deep dive into patient awareness of financial assistance programs, while offering insights into health literacy related to medical…
Image Credit: Adobe Stock Images/BeaunittaVanWyk.com Key Takeaways Alzheimer’s disease affects nearly 6.9 million older U.S. adults, making it the most common form of dementia and a leading cause of long-term…
In a video interview with Pharma Commerce, Maggie McCullough, PolicyMap’s CEO, highlights how geospatial mapping can play a critical role in identifying and addressing pharmacy deserts—areas where access to pharmacies…
Image Credit: Adobe Stock Images/Nattakorn.com Key Takeaways Language barriers reduce access to video-based virtual care: Adult patients facing language barriers are significantly less likely to use video visits compared to…
In a video interview with Pharma Commerce, Maggie McCullough, PolicyMap’s CEO, highlights how geospatial mapping can play a critical role in identifying and addressing pharmacy deserts—areas where access to pharmacies…
Image Credit: Adobe Stock Images/Artur.com Key Takeaways Sanofi is shipping Beyfortus early to ensure strong supply for the 2025–2026 RSV season and avoid past shortages. Sanofi and AstraZeneca have tripled…
PC: Although ways to decrease healthcare costs are certainly encouraged by pharma supply chain stakeholders, what potential long-term repercussions (if any) could President Trump’s MFN executive order have on the…
Preparing for the Pharma C-Suite In a Pharmaceutical Executive feature, Aileen Fernandes, Chief Business Officer at Arcellx, reflects on how her early roles at Morgan Stanley and Deloitte Consulting, combined…
Five Critical Challenges in Investigator Site Selection and How Clinical Data Science Can Solve Them In a Pharmaceutical Executive feature, Gen Li, founder, CEO, Phesi, outlines five key challenges hindering…
Forging a Brighter Future for Rare Disease Outcomes with Specialty Pharmacy Utilization A Pharmaceutical Executive article explores how specialty pharmacy programs can significantly improve outcomes for patients with rare diseases—like…
GLP-1 Drugs may be Linked to Elevated Risk of Serious Eye Disease, Study Finds A new observational study finds that people with diabetes taking GLP-1 drugs have a low but…
Image Credit: Adobe Stock Images/Wladimir1804.com Key Takeaways MA enrollment among full-benefit dual-eligible beneficiaries is rising, reaching nearly 50% by 2022. FIDE-SNP enrollees have greater health and support needs than those…
In a video interview with Pharma Commerce, Maggie McCullough, PolicyMap’s CEO, highlights how geospatial mapping can play a critical role in identifying and addressing pharmacy deserts—areas where access to pharmacies…
In a video interview with Pharma Commerce, Maggie McCullough, PolicyMap’s CEO, highlights how geospatial mapping can play a critical role in identifying and addressing pharmacy deserts—areas where access to pharmacies…
Image Credit: Adobe Stock Images/Hugnaka.com Key Takeaways BioNTech and Bristol Myers Squibb have entered a major global collaboration to co-develop and co-commercialize BNT327, a bispecific antibody for solid tumors, with…
In a video interview with Pharma Commerce, Scott Tillman, Logility’s senior vice president of innovation, addresses the gap between high interest in generative AI (GenAI) and its relatively low adoption…
Image Credit: Adobe Stock Images/Somneuk.com Key Takeaways Tariffs could spike drug costs: Proposed 25% tariffs on pharmaceuticals may raise US drug prices by up to 12.9% and cost the industry…
In a video interview with Pharma Commerce, Scott Tillman, Logility’s senior vice president of innovation, addresses the gap between high interest in generative AI (GenAI) and its relatively low adoption…
Key Takeaways Exceptional CX significantly boosts engagement with healthcare professionals and consumers, leading to increased prescriptions, better market penetration, and improved health outcomes. Pharma companies are leveraging AI-driven omnichannel platforms…
In a video interview with Pharma Commerce, Scott Tillman, Logility’s senior vice president of innovation, addresses the gap between high interest in generative AI (GenAI) and its relatively low adoption…
May 28th 2025 Article When a South Korean patient needed a life-changing gene therapy, Marken orchestrated an international distribution strategy under the strictest regulatory and temperature specifications. With precise temperature-control…
When Coretta learned she had stage 4 non-small cell lung cancer, she was blindsided. She didn’t fit the profile. She didn’t see it coming. And she didn’t know what to…